Dominik Höchli
Director/Miembro de la Junta en MOLECULAR PARTNERS AG .
Perfil
Dominik Höchli is currently the Chief Executive Officer at Catapult Therapeutics BV and an Independent Director at Molecular Partners AG.
He previously worked as the Vice President & Head-Global Medical Affairs at AbbVie AG.
He holds a doctorate degree from the University of Bern.
Cargos activos de Dominik Höchli
| Empresas | Cargo | Inicio |
|---|---|---|
| MOLECULAR PARTNERS AG | Director/Miembro de la Junta | 21/04/2021 |
Catapult Therapeutics BV
 Catapult Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Catapult Therapeutics BV operates as a biopharmaceutical company which develops cancer treatments. It is developing CAP-100, a humanized anti-CCR7 antibody. The company was founded in 2015 and is headquartered in Lelystad, the Netherlands. | Director Ejecutivo | 01/01/2021 |
Antiguos cargos conocidos de Dominik Höchli.
| Empresas | Cargo | Fin |
|---|---|---|
| AbbVie AG | Corporate Officer/Principal | - |
Formación de Dominik Höchli.
| University of Bern | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| MOLECULAR PARTNERS AG | Health Technology |
| Empresas privadas | 2 |
|---|---|
| AbbVie AG | |
Catapult Therapeutics BV
Catapult Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Catapult Therapeutics BV operates as a biopharmaceutical company which develops cancer treatments. It is developing CAP-100, a humanized anti-CCR7 antibody. The company was founded in 2015 and is headquartered in Lelystad, the Netherlands. | Commercial Services |
- Bolsa de valores
- Insiders
- Dominik Höchli
